1. Matthews WB. Slow virus infections. J R Coll Physicians Lond. 1981 Apr;15(2):109-12.
2. Blutinger E, Schmitz G, Kang C, et al. Measles: Contemporary considerations for the emergency physician. J Am Coll Emerg Physicians Open 2023; 4:e13032.
3. Alves Graber EM, Andrade FJ, Jr., Bost W, Gibbs MA. An Update and Review of Measles for Emergency Physicians. J Emerg Med 2020; 58:610-5.
4. Garg RK, Mahadevan A, Malhotra HS, Rizvi I, Kumar N, Uniyal R. Subacute sclerosing panencephalitis. Rev Med Virol 2019; 29:e2058.
5. Ishizaki Y, Takemoto M, Kira R, et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J Neurovirol 2008; 14:486-91.
6. Shimizu T, Matsuishi T, Iwamoto R, et al. Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Infect Dis 2002; 185:1346-50.
7. Chiodi F, Sundqvist VA, Norrby E, Mavra M, Link H. Measles IgM antibodies in cerebrospinal fluid and serum in subacute sclerosing panencephalitis. J Med Virol 1986; 18:149-58.
8. Cece H, Tokay L, Yildiz S, Karakas O, Karakas E, Iscan A. Epidemiological findings and clinical and magnetic resonance presentations in subacute sclerosing panencephalitis. J Int Med Res
2011; 39:594-602.
9. Aydin OF, Senbil N, Kuyucu N, Gürer YK. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. J Child Neurol
2003; 18:104-8.
10. Watanabe M, Hashimoto K, Abe Y, et al. A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In
Vivo. PLoS One 2016; 11:e0162823.
11. Gheuens S, Wüthrich C, Koralnik IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 8:189-215.
12. Eng PM, Turnbull BR, Cook SF, Davidson JE, Kurth T, Seeger JD. Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 2006;
67:884-6.
13. Lima MA, Drislane FW, Koralnik IJ. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006; 66:262-4.
14. Bernard-Valnet R, Koralnik IJ, Du Pasquier R. Advances in Treatment of Progressive Multifocal Leukoencephalopathy. Ann Neurol. 2021 Dec;90(6):865-873. doi: 10.1002/ana.26198. Epub
2021 Sep 7. PMID: 34405435; PMCID: PMC9291129.
15. Piñar-Morales R, Barrero-Hernández F, Aliaga-Martínez L. Human prion diseases: An overview. Med Clin (Barc). 2023 Jun 23;160(12):554-560.
16. Baldwin KJ, Correll CM. Prion Disease. Semin Neurol. 2019 Aug;39(4):428-439.
17. Mead S, Whitfield J, Poulter M, et al. Genetic susceptibility, evolution and the kuru epidemic. Philos Trans R Soc Lond B Biol Sci 2008; 363:3741-6.
18. McKintosh E, Tabrizi SJ, Collinge J. Prion diseases. J Neurovirol 2003; 9:183-93.
19. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368:2061-7.
20. Boëlle PY, Cesbron JY, Valleron AJ. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis 2004; 4:26.
21. Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology. 2017 Apr;37(2):174-188.
22. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128:2026-33.
23. Vascellari S, Orrù CD, Caughey B. Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies. Front Aging Neurosci 2022; 14:853050.
24. Steinhoff BJ, Racker S, Herrendorf G, et al. Accuracy and Reliability of Periodic Sharp Wave Complexes in Creutzfeldt-Jakob Disease. Archives of Neurology 1996; 53:162-6.
25. Tsuboi Y, Doh-Ura K, Yamada T. Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 2009; 29:632-6.
26. Otto M, Cepek L, Ratzka P, et al. Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology 2004; 62:714-8